Back to search
Huntington's Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Huntington's Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Huntington's Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a first-in-human (FIH) study of RG6496 that will assess the safety and tolerability of single-ascending doses of RG6496 administered to huntington's dis…
For participation in this epidemiological study, a single-day visit at the study site is required. Participants will be recruited from Huntington Disease clinic…
The goal of this clinical trial is to test if the drug SKY-0515, an oral medication, can lower harmful proteins linked to Huntington's Disease (HD) and improve…
The purpose is to assess safety and tolerability of votoplam and to determine whether votoplam slows disease progression in patients with early symptomatic Hunt…
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of single or repeat doses of ALN-HTT02.
This is a first-in-human, multi-center trial studying the effects of SRP-1005 in participants with Huntington's disease (HD).
The goal of this clinical trial is to improve communication among clinicians, patients with memory problems, and their family members. We are testing a way to h…
The main goal of the GENEPARK consortium is to employ innovative haemogenomic approaches to determine gene expression profiles specific for genetic and idiopath…